क्लोपिडोग्रेल और फ्लुवोक्सामिन का इंटरैक्शन

CYP2C19 inhibitors: Avoid concomitant use of omeprazole or esomeprazole.

Nonsteroidal anti-inflammatory drugs (NSAIDs), warfarin, selective serotonin and serotonin norepinephrine reuptake inhibitors (SSRIs, SNRIs): Increases risk of bleeding.

SSRIs and SNRIs Since selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) affect platelet activation, the concomitant administration of SSRIs and SNRIs with clopidogrel may increase the risk of bleeding.

The metabolism of clopidogrel can also be impaired by drugs that inhibit CYP2C19, such as omeprazole or esomeprazole.

CYP2C19 Inhibitors Clopidogrel is metabolized to its active metabolite in part by CYP2C19.